Copyright
©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2110-2121
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110
Figure 4 Forest plot for Cox proportional hazards model applied to the followed patients.
Probiotics refers to esomeprazole 20 mg b.i.d. and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules 500 mg t.i.d. treatment; placebo refers to esomeprazole 20 mg b.i.d. and placebo treatment. aP < 0.05; bP < 0.01; cP < 0.001. RDQ: Reflux disease questionnaire; AIC: Akaike information criterion.
- Citation: Sun QH, Wang HY, Sun SD, Zhang X, Zhang H. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World J Gastroenterol 2019; 25(17): 2110-2121
- URL: https://www.wjgnet.com/1007-9327/full/v25/i17/2110.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i17.2110